These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
3. Ocular toxicity during adjuvant chemoendocrine therapy for early breast cancer: results from International Breast Cancer Study Group trials. Gianni L, Panzini I, Li S, Gelber RD, Collins J, Holmberg SB, Crivellari D, Castiglione-Gertsch M, Goldhirsch A, Coates AS, Ravaioli A, International Breast Cancer Study Group (IBCSG). Cancer; 2006 Feb 01; 106(3):505-13. PubMed ID: 16369994 [Abstract] [Full Text] [Related]
4. Retinal changes associated with tamoxifen treatment for breast cancer. Tang R, Shields J, Schiffman J, Li H, Locher D, Hampton J, Prager T, Pardo G. Eye (Lond); 1997 Feb 01; 11 ( Pt 3)():295-7. PubMed ID: 9373465 [Abstract] [Full Text] [Related]
9. [Ocular toxicity caused by tamoxifen: case report]. Inada ET, Watanabe KP, Tanaka SG, Sakakisbara LA. Arq Bras Oftalmol; 2005 Feb 01; 68(4):554-6. PubMed ID: 16322846 [Abstract] [Full Text] [Related]
10. Pseudocystic foveal cavitation in tamoxifen retinopathy. Doshi RR, Fortun JA, Kim BT, Dubovy SR, Rosenfeld PJ. Am J Ophthalmol; 2014 Jun 01; 157(6):1291-1298.e3. PubMed ID: 24582991 [Abstract] [Full Text] [Related]
11. Screening for tamoxifen ocular toxicity: a prospective study. Therssen R, Jansen E, Leys A, Rutten J, Meyskens J. Eur J Ophthalmol; 1995 Jun 01; 5(4):230-4. PubMed ID: 8963159 [Abstract] [Full Text] [Related]
12. Crystalline maculopathy: a rare complication of tamoxifen therapy. Srikantia N, Mukesh S, Krishnaswamy M. J Cancer Res Ther; 2010 Jun 01; 6(3):313-5. PubMed ID: 21119261 [Abstract] [Full Text] [Related]
18. Eye problems in breast cancer patients treated with tamoxifen. Paganini-Hill A, Clark LJ. Breast Cancer Res Treat; 2000 Mar 01; 60(2):167-72. PubMed ID: 10845279 [Abstract] [Full Text] [Related]